Jordi Huguet
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Jordi Huguet has a total of 251 co-authors. Here are the top co-authors by number of shared publications:
- Antonio Alcaraz
Uro-Oncology Unit, Department of Urology, Hospital Clinic de Barcelona, 08036 Barcelona, Spain
6 shared publications L. Peri
4 shared publicationsM.J. Ribal
4 shared publications- Alexandru Ciudin
Urology Department, Hospital Universitari de Mollet, 08100 Barcelona, Spain
3 shared publications M.G. Diaconu
3 shared publicationsALFA Study
2 shared publications
Latest Publications
- Open Access
- 28 October 2026
- Published by SAGE Publications in Journal of Cerebral Blood Flow & Metabolism
Multidomain determinants of perivascular spaces indicate early cerebrovascular vulnerability in individuals at risk of Alzheimer’s disease
Background: Perivascular spaces (PVS) are MRI-visible markers of cerebrovascular and glymphatic function, but their regional determinants in preclinical Alzheimer’s disease (AD), regarding sex and AD biomarkers, remain poorly understood. Methods: We studied 1199 cognitively unimpaired ALFA study participants (aged 54–65 years), genetically enriched for AD risk, with CSF biomarker phenotyping in 296 participants. PVS were automatically quantified in basal ganglia, centrum semiovale, hippocampus, and midbrain on 3T MRI. Counts were modeled using Poisson or negative binomial regression, adjusting for demographics, cardiometabolic, lifestyle, and genetic factors, with effect modification by sex and amyloid/tau (AT) status. Results: PVS showed marked regional specificity. Centrum semiovale PVS were associated with age, male sex, and cardiometabolic factors, whereas hippocampal and midbrain PVS were more closely related to AD biomarker status and sleep or psychological measures. Men exhibited higher centrum semiovale burden while women showed higher counts in hippocampus, midbrain, and basal ganglia. Associations were stronger in amyloid-positive individuals with concurrent tau pathology. Polygenic scores for lipid and metabolic traits contributed modestly to regional PVS variation. Conclusions: PVS burden is associated with multidomain determinants in preclinical AD with regional, sex-specific, and biomarker-dependent patterns, supporting PVS as accessible MRI markers for risk stratification and precision prevention. “Early Identification of Markers in Alzheimer’s Families/ALFA (ALFA Cohort)” ( https://clinicaltrials.gov/study/NCT02485730 ). Registration number: NCT02485730.
- 28 October 2026
- Published by SAGE Publications in Journal of Cerebral Blood Flow & Metabolism
Open AccessMultidomain determinants of perivascular spaces indicate early cerebrovascular vulnerability in individuals at risk of Alzheimer’s disease
Background: Perivascular spaces (PVS) are MRI-visible markers of cerebrovascular and glymphatic function, but their regional determinants in preclinical Alzheimer’s disease (AD), regarding sex and AD biomarkers, remain poorly understood. Methods: We studied 1199 cognitively unimpaired ALFA study participants (aged 54–65 years), genetically enriched for AD risk, with CSF biomarker phenotyping in 296 participants. PVS were automatically quantified in basal ganglia, centrum semiovale, hippocampus, and midbrain on 3T MRI. Counts were modeled using Poisson or negative binomial regression, adjusting for demographics, cardiometabolic, lifestyle, and genetic factors, with effect modification by sex and amyloid/tau (AT) status. Results: PVS showed marked regional specificity. Centrum semiovale PVS were associated with age, male sex, and cardiometabolic factors, whereas hippocampal and midbrain PVS were more closely related to AD biomarker status and sleep or psychological measures. Men exhibited higher centrum semiovale burden while women showed higher counts in hippocampus, midbrain, and basal ganglia. Associations were stronger in amyloid-positive individuals with concurrent tau pathology. Polygenic scores for lipid and metabolic traits contributed modestly to regional PVS variation. Conclusions: PVS burden is associated with multidomain determinants in preclinical AD with regional, sex-specific, and biomarker-dependent patterns, supporting PVS as accessible MRI markers for risk stratification and precision prevention. “Early Identification of Markers in Alzheimer’s Families/ALFA (ALFA Cohort)” ( https://clinicaltrials.gov/study/NCT02485730 ). Registration number: NCT02485730.
- Top Cited Papers
- 3 April 2026
- Published by Springer Nature in Nature Medicine
- Vol. 32 (5) , 1838-1851
The exposome of brain aging across 34 countries
The physical and social exposome affects human aging, and brain clocks may track its effects. However, most studies neglect multidomain exposures (physical, social and political) across diverse settings globally and their associations with brain aging. In this study, we characterized the associations between 73 country-level physical and social exposomal factors and multimodal brain age in 18,701 participants from 34 countries (healthy individuals and those with Alzheimer’s disease, frontotemporal lobar degeneration or mild cognitive impairment). Exposome effects were assessed using generalized additive models and meta-analytic frameworks. Aggregated exposome models explained up to 15.5-fold more variance than individual exposures (delta Akaike information criterion (ΔAIC): 2,034–3,127). Physical exposome was primarily associated with accelerated structural brain aging (limbic, subcortical and cerebellar regions), whereas social exposome was more strongly associated with functional brain aging (frontotemporal and limbic networks). Exposome burden accounted for 3.3−9.1-fold higher risk of accelerated aging, exceeding effects of clinical diagnoses. Findings were out-of-sample validated in cross-sectional and longitudinal designs, remained consistent across clinical subgroups and persisted after adjustment for demographics, age correction bias, cognition, scanner type and data quality. The exposome accelerates brain aging in health and disease, underscoring the need to address physical, social and political inequities.
- 3 April 2026
- Published by Springer Nature in Nature Medicine
- Vol. 32 (5) , 1838-1851
Top Cited PapersThe exposome of brain aging across 34 countries
The physical and social exposome affects human aging, and brain clocks may track its effects. However, most studies neglect multidomain exposures (physical, social and political) across diverse settings globally and their associations with brain aging. In this study, we characterized the associations between 73 country-level physical and social exposomal factors and multimodal brain age in 18,701 participants from 34 countries (healthy individuals and those with Alzheimer’s disease, frontotemporal lobar degeneration or mild cognitive impairment). Exposome effects were assessed using generalized additive models and meta-analytic frameworks. Aggregated exposome models explained up to 15.5-fold more variance than individual exposures (delta Akaike information criterion (ΔAIC): 2,034–3,127). Physical exposome was primarily associated with accelerated structural brain aging (limbic, subcortical and cerebellar regions), whereas social exposome was more strongly associated with functional brain aging (frontotemporal and limbic networks). Exposome burden accounted for 3.3−9.1-fold higher risk of accelerated aging, exceeding effects of clinical diagnoses. Findings were out-of-sample validated in cross-sectional and longitudinal designs, remained consistent across clinical subgroups and persisted after adjustment for demographics, age correction bias, cognition, scanner type and data quality. The exposome accelerates brain aging in health and disease, underscoring the need to address physical, social and political inequities.
- Open Access
Multidomain determinants of perivascular spaces indicate early cerebrovascular vulnerability in individuals at risk of Alzheimer’s disease
Background: Perivascular spaces (PVS) are increasingly recognized as MRI-visible markers of cerebrovascular and glymphatic functions. However, the determinants of regional PVS burden in the preclinical stages of Alzheimer’s disease (AD) remain to be elucidated, particularly when considering the impact of sex and core AD biomarkers. Methods: We studied 1,199 cognitively unimpaired participants from the ALFA cohort, enriched for AD genetic risk and deeply phenotyped, including cerebrospinal fluid (CSF) biomarkers. PVS were automatically quantified in the basal ganglia, centrum semiovale, hippocampus, and midbrain on 3T MRI. Regional PVS counts were modeled using Poisson or negative binomial regression, accounting for demographics, cardiometabolic, lifestyle and genetic factors. Effect modification by sex and CSF amyloid/tau (AT) classification was examined. Results: Determinants of PVS burden showed marked regional specificity. In the centrum semiovale, PVS burden was associated with age, male-sex and cardiometabolic factors. In contrast, hippocampal and midbrain PVS were more closely related to AD biomarker status and to psychological or sleep-related measures. Pronounced sex differences were observed, with men exhibiting higher PVS burden in centrum semiovale, while women showed higher PVS counts in the hippocampus, midbrain and basal ganglia. Associations between vascular, lifestyle, and genetic factors and PVS burden were stronger in amyloid-positive individuals, particularly those with concurrent amyloid and tau pathology, suggesting increased perivascular vulnerability along the AD continuum. Genetic risk scores for metabolic and lipid-related traits contributed modestly and independently to regional PVS variation, with evidence of sex- and biomarker-specific effects. Conclusions: PVS burden reflects multidomain influences on cerebrovascular and clearance dysfunction in preclinical AD, with distinct regional, sex-specific, and biomarker-dependent patterns. These findings support PVS as an accessible MRI marker of early cerebrovascular vulnerability and highlight their potential relevance for risk stratification and precision prevention strategies before symptom onset.
Open AccessMultidomain determinants of perivascular spaces indicate early cerebrovascular vulnerability in individuals at risk of Alzheimer’s disease
Background: Perivascular spaces (PVS) are increasingly recognized as MRI-visible markers of cerebrovascular and glymphatic functions. However, the determinants of regional PVS burden in the preclinical stages of Alzheimer’s disease (AD) remain to be elucidated, particularly when considering the impact of sex and core AD biomarkers. Methods: We studied 1,199 cognitively unimpaired participants from the ALFA cohort, enriched for AD genetic risk and deeply phenotyped, including cerebrospinal fluid (CSF) biomarkers. PVS were automatically quantified in the basal ganglia, centrum semiovale, hippocampus, and midbrain on 3T MRI. Regional PVS counts were modeled using Poisson or negative binomial regression, accounting for demographics, cardiometabolic, lifestyle and genetic factors. Effect modification by sex and CSF amyloid/tau (AT) classification was examined. Results: Determinants of PVS burden showed marked regional specificity. In the centrum semiovale, PVS burden was associated with age, male-sex and cardiometabolic factors. In contrast, hippocampal and midbrain PVS were more closely related to AD biomarker status and to psychological or sleep-related measures. Pronounced sex differences were observed, with men exhibiting higher PVS burden in centrum semiovale, while women showed higher PVS counts in the hippocampus, midbrain and basal ganglia. Associations between vascular, lifestyle, and genetic factors and PVS burden were stronger in amyloid-positive individuals, particularly those with concurrent amyloid and tau pathology, suggesting increased perivascular vulnerability along the AD continuum. Genetic risk scores for metabolic and lipid-related traits contributed modestly and independently to regional PVS variation, with evidence of sex- and biomarker-specific effects. Conclusions: PVS burden reflects multidomain influences on cerebrovascular and clearance dysfunction in preclinical AD, with distinct regional, sex-specific, and biomarker-dependent patterns. These findings support PVS as an accessible MRI marker of early cerebrovascular vulnerability and highlight their potential relevance for risk stratification and precision prevention strategies before symptom onset.
- Open Access
- 25 December 2023
- Published by Wiley in Alzheimer's & Dementia
- Vol. 19 (S16)
CSF Aβ42/40 is associated with neurodegeneration independently of CSF p‐tau in the earliest AD continuum
Background: Soluble Aβ dyshomeostasis is thought to be the earliest detectable alteration in AD, but is believed to have little impact on neurodegeneration. Conversely, the onset of tau pathology in the presence of Aβ drives subsequent neurodegeneration. Here, we aimed to assess the independent contribution of soluble Aβ and tau dyshomeostasis to neurodegeneration, in the earliest stages of the AD continuum.Method: The first 330 consecutive participants of the ALFA+ study with available longitudinal (3.45±0.24 y) MRI, CSF Aβ42, Aβ40, p‐tau181, and NfL at baseline were included. CSF biomarkers were assessed with the Roche NeuroToolKit robust prototype immunoassays and p‐tau181 with the Elecsys® Phospho‐Tau (181P) CSF immunoassay (Roche Diagnostics International Ltd). Gray matter volume (GMv) changes were computed voxelwise using SPM12 on T1w scans. Hippocampal subfields were segmented using ASHS on high‐resolution acquisitions. To detect regions showing early neurodegeneration, correlations between CSF NfL and GMv changes were sought. Then, GMv and hippocampal subfields changes were sought in association with CSF Aβ42/40 and CSF p‐tau181, both alone and after controlling for the other biomarkers. The interactive effect of CSF p‐tau181 and Aβ status (CSF Aβ42/40 < 0.071) on brain structure was determined.Result: Table 1 shows sample’s characteristics. CSF NfL concentrations were associated with longitudinal GMv atrophy in the medial and inferior temporal areas (Fig. 1A). CSF Aβ42/40 significantly predicted GMv atrophy in the hippocampus bilaterally, alone and when controlling for CSF p‐tau181 and NfL (Fig. 1B‐C). CSF p‐tau181 interacted with Aβ status to predict GMv atrophy in the posterior hippocampus bilaterally (Fig. 1D). Longitudinal GMv atrophy in the hippocampal subfields were confirmed in association with CSF Aβ42/40 in the bilateral CA1, dentate gyrus and BA35 (Table 2).Conclusion: Independently of p‐tau, early Aβ dyshomeostasis is associated with longitudinal GMv atrophy in AD‐sensitive brain areas in the early AD continuum. As expected, tau levels were associated with additional atrophy in these regions in Aβ+ individuals. Pathophysiological alterations other than Aβ, but correlated with CSF Aβ levels, might contribute to the observed atrophy patterns. Control of the earliest pathophysiological alterations in AD may have a relevant impact on neurodegeneration, even at the earliest preclinical stages.
- 25 December 2023
- Published by Wiley in Alzheimer's & Dementia
- Vol. 19 (S16)
Open AccessCSF Aβ42/40 is associated with neurodegeneration independently of CSF p‐tau in the earliest AD continuum
Background: Soluble Aβ dyshomeostasis is thought to be the earliest detectable alteration in AD, but is believed to have little impact on neurodegeneration. Conversely, the onset of tau pathology in the presence of Aβ drives subsequent neurodegeneration. Here, we aimed to assess the independent contribution of soluble Aβ and tau dyshomeostasis to neurodegeneration, in the earliest stages of the AD continuum.Method: The first 330 consecutive participants of the ALFA+ study with available longitudinal (3.45±0.24 y) MRI, CSF Aβ42, Aβ40, p‐tau181, and NfL at baseline were included. CSF biomarkers were assessed with the Roche NeuroToolKit robust prototype immunoassays and p‐tau181 with the Elecsys® Phospho‐Tau (181P) CSF immunoassay (Roche Diagnostics International Ltd). Gray matter volume (GMv) changes were computed voxelwise using SPM12 on T1w scans. Hippocampal subfields were segmented using ASHS on high‐resolution acquisitions. To detect regions showing early neurodegeneration, correlations between CSF NfL and GMv changes were sought. Then, GMv and hippocampal subfields changes were sought in association with CSF Aβ42/40 and CSF p‐tau181, both alone and after controlling for the other biomarkers. The interactive effect of CSF p‐tau181 and Aβ status (CSF Aβ42/40 < 0.071) on brain structure was determined.Result: Table 1 shows sample’s characteristics. CSF NfL concentrations were associated with longitudinal GMv atrophy in the medial and inferior temporal areas (Fig. 1A). CSF Aβ42/40 significantly predicted GMv atrophy in the hippocampus bilaterally, alone and when controlling for CSF p‐tau181 and NfL (Fig. 1B‐C). CSF p‐tau181 interacted with Aβ status to predict GMv atrophy in the posterior hippocampus bilaterally (Fig. 1D). Longitudinal GMv atrophy in the hippocampal subfields were confirmed in association with CSF Aβ42/40 in the bilateral CA1, dentate gyrus and BA35 (Table 2).Conclusion: Independently of p‐tau, early Aβ dyshomeostasis is associated with longitudinal GMv atrophy in AD‐sensitive brain areas in the early AD continuum. As expected, tau levels were associated with additional atrophy in these regions in Aβ+ individuals. Pathophysiological alterations other than Aβ, but correlated with CSF Aβ levels, might contribute to the observed atrophy patterns. Control of the earliest pathophysiological alterations in AD may have a relevant impact on neurodegeneration, even at the earliest preclinical stages.
- Open Access
- 24 December 2023
- Published by Wiley in Alzheimer's & Dementia
- Vol. 19 (S10)
CSF Aβ42/40 is associated with neurodegeneration independently of CSF p‐tau in the earliest AD continuum
Background: Soluble Aß dyshomeostasis is thought to be the earliest detectable alteration in AD, but is believed to have little impact on neurodegeneration. Conversely, the onset of tau pathology in the presence of Aß drives subsequent neurodegeneration. Here, we aimed to assess the independent contribution of soluble Aß and tau dyshomeostasis to neurodegeneration, in the earliest stages of the AD continuum.Method: The first 330 consecutive participants of the ALFA+ study with available longitudinal (3.45±0.24 y) MRI, CSF Aß42, Aß40, p‐tau181, and NfL at baseline were included. CSF biomarkers were assessed with the Roche NeuroToolKit robust prototype immunoassays and p‐tau181 with the Elecsys® Phospho‐Tau (181P) CSF immunoassay (Roche Diagnostics International Ltd). Gray matter volume (GMv) changes were computed voxelwise using SPM12 on T1w scans. Hippocampal subfields were segmented using ASHS on high‐resolution acquisitions. To detect regions showing early neurodegeneration, correlations between CSF NfL and GMv changes were sought. Then, GMv and hippocampal subfields changes were sought in association with CSF Aß42/40 and CSF p‐tau181, both alone and after controlling for the other biomarkers. The interactive effect of CSF p‐tau181 and Aß status (CSF Aß42/40 < 0.071) on brain structure was determined.Result: Table 1 shows sample’s characteristics. CSF NfL concentrations were associated with longitudinal GMv atrophy in the medial and inferior temporal areas (Fig. 1A). CSF Aß42/40 significantly predicted GMv atrophy in the hippocampus bilaterally, alone and when controlling for CSF p‐tau181 and NfL (Fig. 1B‐C). CSF p‐tau181 interacted with Aß status to predict GMv atrophy in the posterior hippocampus bilaterally (Fig. 1D). Longitudinal GMv atrophy in the hippocampal subfields were confirmed in association with CSF Aß42/40 in the bilateral CA1, dentate gyrus and BA35 (Table 2).Conclusion: Independently of p‐tau, early Aß dyshomeostasis is associated with longitudinal GMv atrophy in AD‐sensitive brain areas in the early AD continuum. As expected, tau levels were associated with additional atrophy in these regions in Aß+ individuals. Pathophysiological alterations other than Aß, but correlated with CSF Aß levels, might contribute to the observed atrophy patterns. Control of the earliest pathophysiological alterations in AD may have a relevant impact on neurodegeneration, even at the earliest preclinical stages.
- 24 December 2023
- Published by Wiley in Alzheimer's & Dementia
- Vol. 19 (S10)
Open AccessCSF Aβ42/40 is associated with neurodegeneration independently of CSF p‐tau in the earliest AD continuum
Background: Soluble Aß dyshomeostasis is thought to be the earliest detectable alteration in AD, but is believed to have little impact on neurodegeneration. Conversely, the onset of tau pathology in the presence of Aß drives subsequent neurodegeneration. Here, we aimed to assess the independent contribution of soluble Aß and tau dyshomeostasis to neurodegeneration, in the earliest stages of the AD continuum.Method: The first 330 consecutive participants of the ALFA+ study with available longitudinal (3.45±0.24 y) MRI, CSF Aß42, Aß40, p‐tau181, and NfL at baseline were included. CSF biomarkers were assessed with the Roche NeuroToolKit robust prototype immunoassays and p‐tau181 with the Elecsys® Phospho‐Tau (181P) CSF immunoassay (Roche Diagnostics International Ltd). Gray matter volume (GMv) changes were computed voxelwise using SPM12 on T1w scans. Hippocampal subfields were segmented using ASHS on high‐resolution acquisitions. To detect regions showing early neurodegeneration, correlations between CSF NfL and GMv changes were sought. Then, GMv and hippocampal subfields changes were sought in association with CSF Aß42/40 and CSF p‐tau181, both alone and after controlling for the other biomarkers. The interactive effect of CSF p‐tau181 and Aß status (CSF Aß42/40 < 0.071) on brain structure was determined.Result: Table 1 shows sample’s characteristics. CSF NfL concentrations were associated with longitudinal GMv atrophy in the medial and inferior temporal areas (Fig. 1A). CSF Aß42/40 significantly predicted GMv atrophy in the hippocampus bilaterally, alone and when controlling for CSF p‐tau181 and NfL (Fig. 1B‐C). CSF p‐tau181 interacted with Aß status to predict GMv atrophy in the posterior hippocampus bilaterally (Fig. 1D). Longitudinal GMv atrophy in the hippocampal subfields were confirmed in association with CSF Aß42/40 in the bilateral CA1, dentate gyrus and BA35 (Table 2).Conclusion: Independently of p‐tau, early Aß dyshomeostasis is associated with longitudinal GMv atrophy in AD‐sensitive brain areas in the early AD continuum. As expected, tau levels were associated with additional atrophy in these regions in Aß+ individuals. Pathophysiological alterations other than Aß, but correlated with CSF Aß levels, might contribute to the observed atrophy patterns. Control of the earliest pathophysiological alterations in AD may have a relevant impact on neurodegeneration, even at the earliest preclinical stages.
- 1 July 2019
- Published by Wiley in Alzheimer's & Dementia
- Vol. 15 (7S_Part_27)
P4‐280: INTERACTIVE EFFECT OF CSF ABETA42 AND P‐TAU ON HIPPOCAMPAL SUBFIELD VOLUMETRY IN COGNITIVELY UNIMPAIRED SUBJECTS
- 1 July 2019
- Published by Wiley in Alzheimer's & Dementia
- Vol. 15 (7S_Part_27)
P4‐280: INTERACTIVE EFFECT OF CSF ABETA42 AND P‐TAU ON HIPPOCAMPAL SUBFIELD VOLUMETRY IN COGNITIVELY UNIMPAIRED SUBJECTS
- 1 July 2019
- Published by Wiley in Alzheimer's & Dementia
- Vol. 15 (7S_Part_7)
P1‐382: EFFECT OF AGE AND APOE ON HIPPOCAMPAL SUBFIELDS IN COGNITIVELY NORMAL SUBJECTS (N=1168, SINGLE SITE)
- 1 July 2019
- Published by Wiley in Alzheimer's & Dementia
- Vol. 15 (7S_Part_7)
P1‐382: EFFECT OF AGE AND APOE ON HIPPOCAMPAL SUBFIELDS IN COGNITIVELY NORMAL SUBJECTS (N=1168, SINGLE SITE)
- 11 March 2016
- Published by Elsevier in European Urology Supplements
- Vol. 15 (3) , e1099
1099 Recurrence and relapse after partial nephrectomy for small renal masses
- 11 March 2016
- Published by Elsevier in European Urology Supplements
- Vol. 15 (3) , e1099
1099 Recurrence and relapse after partial nephrectomy for small renal masses
- 1 March 2016
- Published by Elsevier in European Urology Supplements
- Vol. 15 (3) , e79-e79a
79 Surgical evolution and results in living related kidney donation after 500 cases
- 1 March 2016
- Published by Elsevier in European Urology Supplements
- Vol. 15 (3) , e79-e79a
79 Surgical evolution and results in living related kidney donation after 500 cases
- 1 April 2015
- Published by Elsevier in European Urology Supplements
- Vol. 14 (2) , eV17
V17 Nerve sparing laparoscopic radical prostatectomy with hydro-dissection, intrafascial technique
- 1 April 2015
- Published by Elsevier in European Urology Supplements
- Vol. 14 (2) , eV17
V17 Nerve sparing laparoscopic radical prostatectomy with hydro-dissection, intrafascial technique